Company details
Noul Co., Ltd. has developed the next generation POC (Point-Of-Care) blood testing platform for resource-limited medical facilities, clinics, and local hospitals. Noul seeks to solve global challenges that threaten human life, to discover novel solutions, and to establish a new gold standard in POC blood testing.
Nouls solution aims to improve accessibility to proper health care by integrating innovations in biology, artificial intelligence, mobile technology, robotics, and software/hardware engineering.
Noul has filed over 65 global patents, conducted more than seven field clinical trials, and has research partnerships with world-class global institutions such as Harvard University, Columbia University, Swiss TPH, and FIND (Foundation for Innovative New Diagnostics) among others.
More
Less